Shadow Star
A rare, poorly-documented hybrid strain with limited verifiable lineage data and no strain-specific clinical research.
Shadow Star is one of many boutique strain names floating around dispensary menus and seed forums without solid documentation. We cannot verify its lineage, its chemistry, or any consistent effect profile from independent sources. What you get under this name will depend entirely on who grew it and which cut they had. Treat any specific claims about THC percentage, terpene dominance, or effects with skepticism until you see a lab COA for the specific batch in front of you.
Overview
"Shadow Star" is a strain name that appears on some dispensary menus and seed listings but lacks documentation in the sources we can verify: breeder catalogs from established seed banks, peer-reviewed chemotype surveys, or regulator-published lab databases. That doesn't mean it doesn't exist — cannabis has thousands of named cuts, many of them regional or one-offs from a single grower. It means we can't responsibly tell you what Shadow Star "is" in any general sense. No data
If you are shopping for it, the only reliable information will come from the certificate of analysis (COA) for the specific batch and the grower's own notes. Treat the name as a label, not a specification.
Chemistry
We have no verifiable cannabinoid or terpene data for Shadow Star from lab aggregators, published chemotype studies, or regulator databases. No data
What we can say generally: modern commercial cannabis is overwhelmingly THC-dominant, with total THC typically in the 15–25% range on flower, and CBD usually under 1% unless the plant is specifically a CBD-rich chemotype [1][2]. Terpene profiles across the market are most often dominated by myrcene, caryophyllene, or limonene, but individual cuts vary widely [3]. Without a COA for your specific Shadow Star batch, assume nothing about its chemistry.
Reported effects
There is no strain-specific clinical research on Shadow Star. There is, in fact, very little strain-specific clinical research on any named cultivar — controlled trials use standardized cannabinoid preparations, not dispensary flower [4]. No data
Anecdotal reports for rare strains like this circulate on forums and review sites, but user reviews are heavily confounded by expectation, dose, tolerance, method of consumption, and the fact that different "Shadow Star" samples may be genetically unrelated. Anecdote
A large 2022 analysis found that commercial strain names correlate poorly with underlying chemistry — samples sharing a name often differ substantially, and samples with different names often cluster together chemically [5]. That's the honest baseline for evaluating any effect claim tied to a strain name.
Lineage
We could not verify a documented parent cross for Shadow Star from any breeder we can confirm. Disputed
Several unrelated things sold as "Shadow Star" or similar names appear across informal listings — this is common for evocative strain names, which tend to get reused by different growers with no shared genetics. If a vendor tells you the lineage (for example, a cross involving popular parents like a Kush or a Cookies line), ask whether that claim traces back to an identifiable breeder release or is inferred from smell and structure. The latter is a guess, not a pedigree.
The broader issue: cannabis has no functioning central registry for cultivar names. Genetic studies have repeatedly shown that strain names in the market are unreliable indicators of actual ancestry [5][6].
Cultivation basics
We have no verified grow data for Shadow Star — no breeder-published flowering time, yield range, height, or difficulty rating from a source we can cite. No data
Generic guidance for an unknown modern hybrid: expect an 8–10 week flowering window indoors, standard photoperiod (12/12 flip), moderate feeding, and standard integrated pest management. If you receive seeds or clones labeled Shadow Star, pheno-hunt: grow several plants, keep notes, and select on what performs in your environment rather than trusting the name. See our general Cannabis Cultivation Basics article for a starting framework.
Marketing vs. reality
Cool name, striking bag appeal, and a story about rare genetics move product. That's the marketing layer, and Shadow Star sits inside it like hundreds of other boutique names.
The reality layer is simpler:
- Strain names in the current market are unreliable [5][6]. Strong evidence
- THC percentage on the label is a weak predictor of subjective effect, and lab-shopping and sample bias inflate reported numbers [7]. Strong evidence
- "Indica vs sativa" labels do not reliably predict effects — this is folklore, not pharmacology [8]. Strong evidence
- The "entourage effect" and specific terpene thresholds (e.g., the popular "myrcene above 0.5% makes it sedating" claim) are not well-supported by controlled human data. Weak / limited
If you like a specific Shadow Star sample from a specific grower, that's a legitimate reason to buy it again from that grower. Extrapolating from the name alone isn't.
Sources
- Peer-reviewed ElSohly MA, Chandra S, Radwan M, Majumdar CG, Church JC. A Comprehensive Review of Cannabis Potency in the United States in the Last Decade. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 2021;6(6):603-606.
- Peer-reviewed Chandra S, Radwan MM, Majumdar CG, Church JC, Freeman TP, ElSohly MA. New trends in cannabis potency in USA and Europe during the last decade (2008–2017). European Archives of Psychiatry and Clinical Neuroscience. 2019;269:5-15.
- Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLoS ONE. 2022;17(5):e0267498.
- Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. 2017.
- Peer-reviewed Watts S, McElroy M, Migicovsky Z, Maassen H, van Velzen R, Myles S. Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants. 2021;7:1330-1334.
- Peer-reviewed Sawler J, Stout JM, Gardner KM, Hudson D, Vidmar J, Butler L, Page JE, Myles S. The Genetic Structure of Marijuana and Hemp. PLoS ONE. 2015;10(8):e0133292.
- Peer-reviewed Jikomes N, Zoorob M. The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific Reports. 2018;8:4519.
- Peer-reviewed Piomelli D, Russo EB. The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research. 2016;1(1):44-46.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.